U.S. Entertainment Stock News

NYSE:IT
NYSE:ITIT

Gartner (IT) Stock May Sit Below Fair Value Despite Fresh AI Demand News

Gartner stock has had a tough run over the past year, yet current valuation checks suggest the share price may now sit below what its Discounted Cash Flow (DCF) and earnings multiple signals imply for intrinsic value. Over the past 12 months the share price has fallen 51.8%, which puts recent gains into context and raises the question of whether sentiment has moved further than the fundamentals. Recent headlines around Gartner's AI forecasts and its role in shaping spending on AI...
NasdaqGS:NXST
NasdaqGS:NXSTMedia

Is Nexstar Media Group (NXST) Below Fair Value On Its Kansas Debate Telecast News?

Nexstar Media Group (NXST) is drawing attention after announcing that its Kansas stations will air a live, multi market telecast of the Democratic governor candidates' debate on July 31 across TV and digital platforms. See our latest analysis for Nexstar Media Group. The debate announcement comes as Nexstar Media Group’s recent momentum has picked up, with a 7 day share price return of 8.71% and a 30 day share price return of 10.27%, even though the year to date share price return is down...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

What Viatris (VTRS)'s FDA Approval of Weekly Gwyn Lo Contraceptive Patch Means For Shareholders

Viatris Inc. recently received U.S. Food and Drug Administration approval for Gwyn Lo, a once-weekly low-estrogen combined hormonal contraceptive patch for women with a body mass index below 30 kg/m², supported by Phase 3 data showing contraceptive efficacy, a well-characterized safety profile and strong patch adhesion. By adding a low-dose, non-invasive, weekly contraceptive option that targets women seeking convenience and reversibility, Viatris is broadening its branded and complex...
NYSE:IP
NYSE:IPPackaging

International Paper (IP) Stock Looks Undervalued On Fair Value But Richer On Sales

International Paper has delivered a 33.3% gain over the past three years, yet the stock still screens as undervalued on key valuation checks, which puts the recent price moves and containerboard news in sharp focus for investors. A 33.3% return over three years suggests International Paper has already rewarded patient shareholders. The question is whether the current price still leaves room for further upside or now embeds much of that progress. Recent containerboard price increase plans and...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

Tarsus Pharmaceuticals (TARS) Could Be 38% Undervalued Following Cautious Earnings Expectations

Investors are watching Tarsus Pharmaceuticals (TARS) ahead of its upcoming quarterly report, with expectations for a loss alongside higher revenue compared with last year and a cautious Zacks Rank of #4. See our latest analysis for Tarsus Pharmaceuticals. At a share price of US$58.52, Tarsus Pharmaceuticals has seen its share price decline 27.6% year to date, even though the 1 year total shareholder return is 46.3%. This suggests long term holders are still sitting on strong gains despite...
NYSE:COF
NYSE:COFConsumer Finance

Synchrony Financial Stock And Two Consumer Lenders Under Pressure From High Rates

Consumer lending stocks are feeling the strain as the Federal Reserve holds rates steady and energy driven inflation keeps household budgets tight. With borrowing costs elevated and credit cards, auto loans, and mortgages all putting pressure on consumers, some companies exposed to this news are facing tougher conditions than others. This article focuses on three consumer lending stocks that appear more vulnerable to the current rate and inflation backdrop. Each section explains how the...
NYSE:TFX
NYSE:TFXMedical Equipment

Teleflex (TFX) Wins FDA Approval For EZPLAZ, Is The Stock Still Below Fair Value?

Why Teleflex Stock Is Back in Focus After EZPLAZ FDA Approval Teleflex (TFX) is drawing fresh attention after the U.S. Food and Drug Administration approved EZPLAZ Freeze Dried Plasma, the first FDA licensed freeze dried plasma product for urgent bleeding situations. The approval gives Teleflex its first biologics license for a blood component and introduces a plasma option designed for environments where traditional frozen products are hard to store or prepare, including battlefield and...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

Is Capital Clean Energy Carriers (CCEC) Fairly Valued As Q2 Earnings Show Higher Sales But Lower Profit?

Capital Clean Energy Carriers (CCEC) stock is in focus after the company reported second quarter 2026 earnings, which showed higher sales alongside slightly lower net income and earnings per share compared with the same period last year. See our latest analysis for Capital Clean Energy Carriers. At a share price of $22.72, Capital Clean Energy Carriers has logged an 8.86% 1 month share price return and an 11.32% year to date share price return. Its 1 year total shareholder return is broadly...
NYSE:FBP
NYSE:FBPBanks

Is Stronger Q2 Earnings And Capital Returns Altering The Investment Case For First BanCorp (FBP)?

In July 2026, First BanCorp. reported second-quarter 2026 results showing higher net interest income of US$229.13 million and net income of US$96.15 million year-on-year, alongside lower net charge-offs of US$15.98 million, completion of a US$112.78 million share repurchase program, and affirmation of a US$0.20 quarterly dividend. Together, stronger earnings, reduced credit losses, ongoing dividends, and completed buybacks highlight how First BanCorp. is actively returning capital while...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop (WING) Stock May Be 14% Undervalued Despite Sales Declines

Wingstop stock has fallen 61.9% over the past year, yet the current checks send mixed signals on value, with an intrinsic value estimate from a Discounted Cash Flow (DCF) approach pointing to upside while earnings based multiples screen the shares as expensive. Recent news around soft same store sales and loyalty driven promotions adds another layer to how investors may think about what a fair price for Wingstop looks like today. Wingstop is down 61.9% over the last year, which puts the...
NYSE:HRB
NYSE:HRBConsumer Services

Does H&R Block's (HRB) New Analyst Coverage Reframe Its Defensive Profile or Just Confirm Consensus?

Recently, Stephens & Co. initiated research coverage on H&R Block with an Equal-Weight rating, adding another institutional voice to the tax preparer’s analyst following. This new coverage lands after past strong earnings and guidance raised in May, potentially sharpening investor focus on the company’s defensive profile and relative valuation. Next, we’ll examine how this fresh analyst coverage and heightened visibility may influence H&R Block’s broader investment narrative. Capitalize on...
NYSE:TREX
NYSE:TREXBuilding

How Mixed Earnings Signals At Trex Company (TREX) Have Changed Its Investment Story

Earlier this week, analysts highlighted that Trex Company is expected to report a year-over-year earnings decline on higher revenues for the June 2026 quarter, with consensus EPS estimates revised upward over the past month but still pointing to weaker profitability. An interesting wrinkle is that Trex currently carries a top-tier Zacks Rank alongside a negative Earnings ESP, underscoring how diverging analyst signals are sharpening attention on the upcoming results. Next, we’ll examine how...
NYSE:GRMN
NYSE:GRMNConsumer Durables

Workday Stock And Other Founder Led Software Picks Worth Watching

Inflation, central bank decisions and energy prices are keeping markets on edge, which makes it harder to rely on short term signals. Founder led companies offer a different anchor. These leaders often have reputations, wealth and careers tied directly to the long term outcome of their stock. The Founder-Led Companies screener focuses on this alignment. It does not track a single sector or story, which can help you stay flexible as conditions change. In this article you will see three stocks...
NYSE:OHI
NYSE:OHIHealth Care REITs

Omega Healthcare Investors (OHI) Stock May Still Trade Below Fair Value

Omega Healthcare Investors has delivered a strong 115.8% total return over the past five years, and the latest valuation work suggests the stock may still trade below an estimate of intrinsic value based on Discounted Cash Flow, rather than looking stretched after that run. A 115.8% return over five years suggests long term holders in Omega Healthcare Investors have already been well rewarded. Any further upside case now rests on whether the current price still leaves a margin against...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

Marex Group (MRX) Could Be 13% Undervalued After Its Recent Pullback

Marex Group (MRX) stock has drawn attention after recent trading performance, with the price closing at US$63.14. Investors are weighing this move against the company’s latest financial metrics and business mix. See our latest analysis for Marex Group. For context, Marex Group’s recent pullback, with a 1-day share price return of 1.59% lower and 7-day share price return of 4.12% lower, comes after strong momentum. This includes a 30-day share price return of 7.13%, a 90-day share price return...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Upstart (UPST) Secures $4 Billion Castlelake Loan Funding Deal

Upstart Holdings (NasdaqGS:UPST) announced a new multi-year forward-flow loan agreement with Castlelake. The program totals up to US$4b in committed funding capacity for Upstart-powered loans. This is the largest forward-flow program between Upstart and Castlelake so far. Upstart Holdings operates an AI-driven lending platform that connects consumers, banks and credit unions. Access to committed funding is central for a company that depends on third-party capital providers to purchase and...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian (TEAM) Stock Still Looks Reasonable Despite Weak Cash Flow Questions

Atlassian stock has staged a sharp short term rebound but sits on a long stretch of weak returns, which contrasts with valuation checks that currently lean toward the shares looking cheap on several standard measures. Over the past 5 years, Atlassian has delivered a cumulative decline of 69.4%, which frames today’s share price near US$104 as a recovery off a much lower base rather than a long run success story. Expectations around Atlassian’s ability to convert its software revenue into...
NasdaqGS:ALLT
NasdaqGS:ALLTSoftware

US Cybersecurity Stocks Facing New AI Rules What Investors Should Watch

US cybersecurity stocks sit at the crossroads of two powerful forces. On one side are rising concerns about AI being misused in hacks and cross border data theft. On the other are signs that regulators may tighten control of high risk AI tools after recent OpenAI related incidents. That mix can pressure some AI heavy giants while potentially giving select security focused players a relative edge. This article looks at 3 US cybersecurity stocks from the screener that appear closely exposed to...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX) Stock Looks Cheap On Earnings But Weak On Execution

Boston Scientific stock has fallen about 56.9% over the past year, yet the valuation checks still lean supportive, which raises the question of whether the share price has moved further than the fundamentals suggest. The roughly 56.9% decline over the last 12 months means existing shareholders have taken a heavy hit, while potential new buyers are looking at a much lower entry point. The global restructuring plan that targets lower ongoing costs can support valuation over time. However, the...
NYSE:PATH
NYSE:PATHSoftware

UiPath (PATH) After Its Rebound, Does The Automation Story Still Leave Shares Cheap?

UiPath (PATH) continues to draw attention after recent trading left the stock at a last close of US$12.59. Investors are weighing its automation platform, international footprint and current share performance across different timeframes. See our latest analysis for UiPath. The recent 1 day share price return of 3.28% and 7 day share price return of 17.66% sit against a year to date share price decline of 20.72%, while the 1 year total shareholder return of 4.83% points to mixed but improving...
NasdaqCM:WSC
NasdaqCM:WSCConstruction

Is WillScot (WSC) Using Quick-Connect Canopies To Deepen Its Modular Ecosystem Advantage?

WillScot Holdings recently expanded its Clearspan portfolio by launching the Quick-Connect Canopy, a rapidly deployable, ISO-mounted fabric structure that creates covered workspace between compatible modular units, now available across select major U.S. markets. This product introduces a new way for customers to integrate modular buildings, storage containers and ground-level offices into weather-protected, workflow-optimized compounds for construction, industrial and event operations. Next,...
NasdaqCM:NN
NasdaqCM:NNSoftware

The Bull Case For NextNav (NN) Could Change Following Safran 5G PNT Interoperability Deal - Learn Why

In July 2026, NextNav Inc. announced an agreement with Safran Electronics & Defense to integrate and test interoperability between NextNav's terrestrial 5G Positioning, Navigation, and Timing network in Santa Clara County and Safran’s timing and navigation receiver for mission-critical uses such as drones, autonomous systems, critical infrastructure, and public safety. The collaboration highlights how 5G-powered 3D PNT signals could act as a complementary, more resilient layer alongside GPS...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Luckin Coffee (OTCPK:LKNC.Y) Teams Up With Duolingo, Is A 29% Undervalued View Warranted?

Luckin Coffee (OTCPK:LKNC.Y) has moved into the spotlight after announcing a limited-time partnership with language app Duolingo. The collaboration ties summer beverages and merchandise to a back-to-school learning theme aimed at Gen Z customers. See our latest analysis for Luckin Coffee. Luckin Coffee's recent Duolingo partnership arrives after a strong 30-day share price return of 15.66%, although the share price is still down 8.22% year to date and the 1-year total shareholder return is...
NYSE:SPNT
NYSE:SPNTInsurance

SiriusPoint (SPNT): Do Higher EPS And A New COO Redefine Its Profitability Playbook?

SiriusPoint Ltd. has reported past second-quarter 2026 results showing revenue of US$744.1 million versus US$748.2 million a year earlier, with net income rising to US$68.6 million and diluted earnings per share from continuing operations increasing to US$0.58 from US$0.50. Despite slightly lower revenue, SiriusPoint delivered higher profitability and has also strengthened its leadership bench with the appointment of a new Chief Operating Officer to drive technology and operational...